Abstract:Background The effects of seasonal influenza vaccination on cardiovascular disease (CVD) outcomes, including among individuals with established CVD, are uncertain. Methods To evaluate the efficacy and safety of influenza vaccines compared to no vaccines or placebo for preventing all-cause/CVD mortality or all-cause/CVD hospitalization in the general population and in populations with pre-existing CVD, we conducted a living systematic review (LSR) and prospective meta-analysis (PMA). Published randomized controlled trials (RCT) and observational studies between 1994 and 2023 were searched. PRISMA guidelines were followed in the extraction of study details, and risk of bias was assessed using the Cochrane tools. Analyses were stratified by study design and CVD history. Study quality was evaluated using GRADE system. Meta analyses based on random-effects models were performed between July and October 2022. Pooled risk ratios (RRs) for all-cause/CVD mortality and all-cause/CVD hospitalization were main outcomes. Results Six published RCTs comprising 12,662 participants (mean age, 62 years; 45 % women; 8,797 with pre-existing CVD) and 37 observational studies comprising 6,311,703 participants (mean age, 49 years; 50 % women; 1,189,955 with pre-existing CVD) were included. Only those RCTs judged to be low risk were included in the analyses, and observational studies at anything greater than moderate risk of bias were excluded. In RCTs, influenza vaccine was not significantly associated with lower all-cause mortality (RR, 0.85; 95 %CI, 0.61–1.17), cardiovascular death (RR, 0.80; 95 %CI, 0.60–1.07), or CVD hospitalization (RR, 0.69; 95 %CI, 0.47–1.02). A statistically significant reduction in all-cause hospitalization (RR, 0.86; 95 %CI, 0.76–0.97) was observed. The evidence level was assessed as moderate for all-cause hospitalization, and low for other outcomes. Overall, observational studies suggested a stronger protective association between influenza vaccination and outcomes, except for CVD hospitalization. Based on RCTs, there was no difference in the effects of influenza vaccination on all-cause mortality among the general population compared to those with pre-existing CVD, although the summary point estimate favored benefits only in those with pre-existing CVD. Conclusions While observational studies suggest that influenza vaccination may be associated with lower all-cause and CVD mortality and all-cause hospitalization, RCTs reported to date suggest a reduction in the risk of all-cause hospitalization but do not provide clear evidence to support preventive effects on mortality (all-cause or CVD) or CVD hospitalization.

Association of Influenza Vaccination and Dementia Risk: A Meta-Analysis of Cohort Studies

The effect of influenza vaccination on the rate of dementia amongst older adults

Prospective cohort study evaluating the association between influenza vaccination and neurodegenerative diseases

Adult Vaccination as a Protective Factor for Dementia: A Meta-Analysis and Systematic Review of Population-Based Observational Studies

Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching

The Association Between Influenza Vaccination and COVID-19 and Its Outcomes: A Systematic Review and Meta-Analysis of Observational Studies

Influenza vaccine effect on risk of stroke occurrence: a systematic review and meta-analysis

Effectiveness of Influenza Vaccination on In-Hospital Death in Older Adults with Respiratory Diseases.

Heightened Prevalence of Common Hospital-Treated Infections Preceding Dementia Diagnosis with Accelerated Dementia Onset after Influenza

Influenza vaccination is associated with a decreased risk of atrial fibrillation: A systematic review and meta-analysis

Association between influenza vaccination and SARS-CoV-2 infection and its outcomes: systematic review and meta-analysis

The association between influenza vaccination, cardiovascular mortality and hospitalization: A living systematic review and prospective meta-analysis

Effectiveness of Influenza Vaccination on In-Hospital Death and Recurrent Hospitalization in Older Adults with Cardiovascular Diseases.

The Effectiveness of Influenza Vaccine among Elderly Chinese: A Regression Discontinuity Design Based on Yinzhou Regional Health Information Platform

Influenza vaccination and COVID-19 infection risk and disease severity: A systematic review and multilevel meta-analysis of prospective studies

Influenza Vaccination and COVID19 Mortality in the USA

Protection against influenza hospitalizations from enhanced influenza vaccines among older adults: A systematic review and network meta-analysis

Mortality associated with an influenza outbreak on a dementia care unit

Effectiveness of Influenza Vaccination on Hospitalization Outcomes among Older Patients with Diabetes

Influenza Vaccination And Hospitalization Outcomes Among Older Patients With Cardiovascular Or Respiratory Diseases

Association Between Vitamin D and Influenza: Meta-Analysis and Systematic Review of Randomized Controlled Trials